Metabolomic analysis of Streptococcus pneumoniae: uncovering key metabolic pathways

Haiyan Jiang1, Changliang Zhao1, Lu Feng1

  • 1Department of Paediatric, The Third Worker's Hospital of BaoGang Group, Baotou, Inner Mongolia, China.

Frontiers in Microbiology
|December 22, 2025
PubMed
Abstract

Insights

This study reveals significant metabolic changes in individuals with pneumococcal infection, identifying key biomarkers and pathways. These findings offer new targets for diagnosing and treating Streptococcus pneumoniae infections.

Area of Science:

  • Metabolomics
  • Infectious Disease Research
  • Systems Biology

Background:

  • Pneumococcal infection, caused by Streptococcus pneumoniae, is a major cause of pneumonia and other severe illnesses.
  • Understanding the molecular mechanisms of S. pneumoniae pathogenesis is challenging due to its complex etiology.

Purpose of the Study:

  • To comprehensively analyze the serum metabolome in pneumococcal infection.
  • To identify differential metabolites and enriched metabolic pathways associated with S. pneumoniae infection.
  • To provide a foundation for developing diagnostic and therapeutic strategies.

Main Methods:

  • Serum samples from infected individuals and controls were analyzed using liquid chromatography/mass spectrometry (LC-MS).
  • Multivariate statistical analyses (PCA, OPLS-DA) were used for metabolite identification.
  • Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis mapped metabolic pathways.

Main Results:

  • 418 significant metabolites differentiating infected and control groups were identified.
  • Metabolites included amino acids, fatty acids, and phosphatidylcholine.
  • Enriched pathways involved galactose metabolism, HIF-1 signaling, the citrate cycle, pentose phosphate pathway, and glycolysis/gluconeogenesis, indicating immune response activation.

Conclusions:

  • The study offers a real-time analysis of the metabolic network during pneumococcal infection.
  • Identified metabolic biomarkers and pathways provide targets for diagnosing and treating pneumococcal infections.